Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Payables (2018 - 2025)

Viemed Healthcare's Payables history spans 8 years, with the latest figure at $7.3 million for Q4 2025.

  • For Q4 2025, Payables rose 37.79% year-over-year to $7.3 million; the TTM value through Dec 2025 reached $7.3 million, up 37.79%, while the annual FY2025 figure was $7.3 million, 37.79% up from the prior year.
  • Payables reached $7.3 million in Q4 2025 per VMD's latest filing, down from $8.7 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $8.7 million in Q3 2025 to a low of $2.5 million in Q2 2021.
  • Average Payables over 5 years is $5.2 million, with a median of $5.0 million recorded in 2021.
  • Peak YoY movement for Payables: crashed 60.28% in 2021, then skyrocketed 66.59% in 2023.
  • A 5-year view of Payables shows it stood at $3.2 million in 2021, then dropped by 18.18% to $2.6 million in 2022, then surged by 57.74% to $4.2 million in 2023, then rose by 27.32% to $5.3 million in 2024, then surged by 37.79% to $7.3 million in 2025.
  • Per Business Quant, the three most recent readings for VMD's Payables are $7.3 million (Q4 2025), $8.7 million (Q3 2025), and $8.3 million (Q2 2025).